Magnetic Resonance-Guided High-Intensity Focused Ultrasound: Gynecological Applications

Reference work entry


High-intensity focused ultrasound (HIFU) is an exciting ablative technology that promises noninvasive direct and indirect treatment of a variety of benign and malignant disorders including solid tumors. Although the HIFU concept has been existent for several decades, its most recent iterations have enabled proof of concept treatment in both benign tumors such as uterine leiomyomas and also malignant tumors in liver, bone, pancreas, and prostate. In this chapter, we focus on HIFU applications for treatment of uterine leiomyomas. We will review clinical manifestations, imaging characteristics, treatment options, and approaches to patients; we will also discuss short- and long-term outcomes of patients with symptomatic leiomyomas treated with HIFU. Finally, we will discuss less common applications of HIFU including cervical ectopy and abdominal wall endometriosis.


Uterine Artery Embolization Uterine Fibroid Uterine Leiomyomas Future Fertility HIFU Treatment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Haar GT, Coussios C. High intensity focused ultrasound: past, present and future. Int J Hyperthermia. 2007;23:85–7.CrossRefPubMedGoogle Scholar
  2. 2.
  3. 3.
    Day Baird D, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188:100–7.CrossRefGoogle Scholar
  4. 4.
    Parazzini F, Negri E, La Vecchia C, Chatenoud L, Ricci E, Guarnerio P. Reproductive factors and risk of uterine fibroids. Epidemiology. 1996;7:440–2.CrossRefPubMedGoogle Scholar
  5. 5.
    Spies JB, Coyne K, Guaou Guaou N, Boyle D, Skyrnarz-Murphy K, Gonzalves SM. The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol. 2002;99:290–300.PubMedGoogle Scholar
  6. 6.
    Flynn M, Jamison M, Datta S, Myers E. Health care resource use for uterine fibroid tumors in the United States. Am J Obstet Gynecol. 2006;195:955–64.CrossRefPubMedGoogle Scholar
  7. 7.
    Hartmann KE, Birnbaum H, Ben-Hamadi R, et al. Annual costs associated with diagnosis of uterine leiomyomata. Obstet Gynecol. 2006;108:930–7.CrossRefPubMedGoogle Scholar
  8. 8.
    Wise LA, Radin RG, Palmer JR, Kumanyika SK, Rosenberg L. A prospective study of dairy intake and risk of uterine leiomyomata. Am J Epidemiol. 2010;171:221–32.CrossRefPubMedGoogle Scholar
  9. 9.
    Liu JP, Yang H, Xia Y, Cardini F. Herbal preparations for uterine fibroids. Cochrane Database Syst Rev. 2009;2:CD005292. PMID 19370619.Google Scholar
  10. 10.
    Nowak RA. Fibroids: pathophysiology and current medical treatment. Baillieres Best Pract Res Clin Obstet Gynaecol. 1999;13:223–38.CrossRefPubMedGoogle Scholar
  11. 11.
    Zhang Y, Peng W, Clarke J, Liu Z. Acupuncture for uterine fibroids. Cochrane Database Syst Rev. 2010;1:CD007221. PMID 2009162.Google Scholar
  12. 12.
    McCracken G, Hunter D, Morgan D, Price JH. Comparison of laparoscopic-assisted vaginal hysterectomy, total abdominal hysterectomy and vaginal hysterectomy. Ulster Med J. 2006;75:54–8.PubMedPubMedCentralGoogle Scholar
  13. 13.
    Karasick S, Spettell CM. The role of parity and hysterectomy on the development of pelvic floor abnormalities revealed by defecography. AJR Am J Roentgenol. 1997;169:1555–8.CrossRefPubMedGoogle Scholar
  14. 14.
    Dallenbach P, Kaelin-Gambirasio I, Dubuisson JB, Boulvain M. Risk factors for pelvic organ prolapse repair after hysterectomy. Obstet Gynecol. 2007;110:625–32.CrossRefPubMedGoogle Scholar
  15. 15.
    Lumsden MA. Embolization versus myomectomy versus hysterectomy: which is best, when? Hum Reprod. 2002;17:253–9.CrossRefPubMedGoogle Scholar
  16. 16.
    Gupta JK, Sinha AS, Lumsden MA, Hickey M. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database Syst Rev. 2006;1:CD005073. PMID 16437515.Google Scholar
  17. 17.
    Spilsbury K, Hammond I, Bulsara M, Semmens JB. Morbidity outcomes of 78,577 hysterectomies for benign reasons over 23 years. BJOG. 2008;115:1473–83.CrossRefPubMedGoogle Scholar
  18. 18.
    Fedele L, Parazzini F, Luchini L, Mezzopane R, Tozzi L, Villa L. Recurrence of fibroids after myomectomy: a transvaginal ultrasonographic study. Hum Reprod. 1995;10:1795–6.CrossRefPubMedGoogle Scholar
  19. 19.
    Yoo EH, Lee PI, Huh CY, et al. Predictors of leiomyoma recurrence after laparoscopic myomectomy. J Minim Invasive Gynecol. 2007;14:690–7.CrossRefPubMedGoogle Scholar
  20. 20.
    Malone LJ. Myomectomy: recurrence after removal of solitary and multiple myomas. Obstet Gynecol. 1969;34:200–3.PubMedGoogle Scholar
  21. 21.
    Buttram Jr VC. Uterine leiomyomata–aetiology, symptomatology and management. Prog Clin Biol Res. 1986;225:275–96.PubMedGoogle Scholar
  22. 22.
    Fauconnier A, Chapron C, Babaki-Fard K, Dubuisson JB. Recurrence of leiomyomata after myomectomy. Hum Reprod Update. 2000;6:595–602.CrossRefPubMedGoogle Scholar
  23. 23.
    Ravina JH, Herbreteau D, Ciraru-Vigneron N, et al. Arterial embolisation to treat uterine myomata. Lancet. 1995;346:671–2.CrossRefPubMedGoogle Scholar
  24. 24.
    Goodwin SC, Vedantham S, McLucas B, Forno AE, Perrella R. Preliminary experience with uterine artery embolization for uterine fibroids. J Vasc Interv Radiol. 1997;8:517–26.CrossRefPubMedGoogle Scholar
  25. 25.
    Siskin GP, Shlansky-Goldberg RD, Goodwin SC, et al. A prospective multicenter comparative study between myomectomy and uterine artery embolization with polyvinyl alcohol microspheres: long-term clinical outcomes in patients with symptomatic uterine fibroids. J Vasc Interv Radiol. 2006;17:1287–95.CrossRefPubMedGoogle Scholar
  26. 26.
    Volkers NA, Hehenkamp WJ, Birnie E, et al. Uterine artery embolization in the treatment of symptomatic uterine fibroid tumors (EMMY trial): periprocedural results and complications. J Vasc Interv Radiol. 2006;17:471–80.CrossRefPubMedGoogle Scholar
  27. 27.
    Volkers NA, Hehenkamp WJ, Birnie E, Ankum WM, Reekers JA. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years’ outcome from the randomized EMMY trial. Am J Obstet Gynecol. 2007;196:519 e1–11.CrossRefGoogle Scholar
  28. 28.
    Spies JB, Ascher SA, Roth AR, Kim J, Levy EB, Gomez-Jorge J. Uterine artery embolization for leiomyomata. Obstet Gynecol. 2001;98:29–34.PubMedGoogle Scholar
  29. 29.
    Jolesz FA. MRI-guided focused ultrasound surgery. Annu Rev Med. 2009;60:417–30.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
  31. 31.
    Stewart EA, Gedroyc WM, Tempany CM, et al. Focused ultrasound treatment of uterine fibroid tumors: safety and feasibility of a noninvasive thermoablative technique. Am J Obstet Gynecol. 2003;189:48–54.CrossRefPubMedGoogle Scholar
  32. 32.
    Jolesz FA, Hynynen K, McDannold N, Tempany C. MR imaging-controlled focused ultrasound ablation: a noninvasive image-guided surgery. Magn Reson Imaging Clin N Am. 2005;13:545–60.CrossRefPubMedGoogle Scholar
  33. 33.
    Ren XL, Zhou XD, Zhang J, et al. Extracorporeal ablation of uterine fibroids with high-intensity focused ultrasound: imaging and histopathologic evaluation. J Ultrasound Med. 2007;26:201–12.CrossRefPubMedGoogle Scholar
  34. 34.
    Ren XL, Zhou XD, Yan RL, et al. Sonographically guided extracorporeal ablation of uterine fibroids with high-intensity focused ultrasound: midterm results. J Ultrasound Med. 2009;28:100–3.CrossRefPubMedGoogle Scholar
  35. 35.
    Yoon SW, Lee C, Cha SH, et al. Patient selection guidelines in MR-guided focused ultrasound surgery of uterine fibroids: a pictorial guide to relevant findings in screening pelvic MRI. Eur Radiol. 2008;18:2997–3006.CrossRefPubMedGoogle Scholar
  36. 36.
    Yoon S-W. Magnetic resonance-guided focused ultrasound treatment of uterine fibroids in patients with abdominal scars, using an energy-blocking scar patch. In: MR-guided focused ultrasound 2010, Washington, DC;2010. p. 122.Google Scholar
  37. 37.
    Gorny KR, Chen S, Hangiandreou NJ, et al. Initial evaluation of acoustic reflectors for the preservation of sensitive abdominal skin areas during MRgFUS treatment. Phys Med Biol. 2009;54:N125–33.CrossRefPubMedGoogle Scholar
  38. 38.
    Smart OC, Hindley JT, Regan L, Gedroyc WG. Gonadotrophin-releasing hormone and magnetic-resonance-guided ultrasound surgery for uterine leiomyomata. Obstet Gynecol. 2006;108:49–54.CrossRefPubMedGoogle Scholar
  39. 39.
    LeBlang SD. Patient selection for MRgFUS in the treatment of uterine fibroids. In: MR-guided focused ultrasound 2010 2nd International Symposium. Washington, DC;2010. p. 116.Google Scholar
  40. 40.
    Machtinger R, Fennessy FM, Stewart EA, Tempany CA. Analyzing screen failures prior to MRgFUS for uterine fibroids: do African American (AA) women have different characteristics?. In: MR-guided focused ultrasound. Washington, DC; 2010Google Scholar
  41. 41.
    Summary of safety and effectiveness data. (2004). Accessed 3 June 2004.
  42. 42.
    Wamsteker K, Emanuel MH, de Kruif JH. Transcervical hysteroscopic resection of submucous fibroids for abnormal uterine bleeding: results regarding the degree of intramural extension. Obstet Gynecol. 1993;82:736–40.PubMedGoogle Scholar
  43. 43.
    Lenard ZM, McDannold NJ, Fennessy FM, et al. Uterine leiomyomas: MR imaging-guided focused ultrasound surgery–imaging predictors of success. Radiology. 2008;249:187–94.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Hananel A. The next generation fo ExAblate. In: Tan N, editor. Los Angeles:2010.
  45. 45.
    Hindley J, Gedroyc WM, Regan L, et al. MRI guidance of focused ultrasound therapy of uterine fibroids: early results. AJR Am J Roentgenol. 2004;183:1713–9.CrossRefPubMedGoogle Scholar
  46. 46.
    Stewart EA, Rabinovici J, Tempany CM, et al. Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril. 2006;85:22–9.CrossRefPubMedGoogle Scholar
  47. 47.
    Fennessy FM, Tempany CM, McDannold NJ, et al. Uterine leiomyomas: MR imaging-guided focused ultrasound surgery–results of different treatment protocols. Radiology. 2007;243:885–93.CrossRefPubMedGoogle Scholar
  48. 48.
    Funaki K, Fukunishi H, Funaki T, Sawada K, Kaji Y, Maruo T. Magnetic resonance-guided focused ultrasound surgery for uterine fibroids: relationship between the therapeutic effects and signal intensity of preexisting T2-weighted magnetic resonance images. Am J Obstet Gynecol. 2007;196:184 e1–6.CrossRefGoogle Scholar
  49. 49.
    Stewart EA, Gostout B, Rabinovici J, Kim HS, Regan L, Tempany CM. Sustained relief of leiomyoma symptoms by using focused ultrasound surgery. Obstet Gynecol. 2007;110:279–87.CrossRefPubMedGoogle Scholar
  50. 50.
    Funaki K, Fukunishi H, Sawada K. Clinical outcomes of magnetic resonance-guided focused ultrasound surgery for uterine myomas: 24-month follow-up. Ultrasound Obstet Gynecol. 2009;34:584–9.CrossRefPubMedGoogle Scholar
  51. 51.
    LeBlang SD, Hoctor K, Steinberg FL. Leiomyoma shrinkage after MRI-guided focused ultrasound treatment: report of 80 patients. AJR Am J Roentgenol. 2010;194:274–80.CrossRefPubMedGoogle Scholar
  52. 52.
    Kurashvili J, Stepanov A, Batarchina O, et al. MRgFUS treatment for uterine myomas: safety, effectiveness and pathogenesis. In: MR-guided focused ultrasound 2010 2nd International Symposium; 2010 Oct 17; Washington, DC; 2010. p. 117.Google Scholar
  53. 53.
    Kim Y-s, Lim HK, Kim J-H, Rhim H, Keserci B. Dynamic contrast-enhanced magnetic resonance imaging predicts immediate therapeutic response of MR-guided high-intensity focused ultrasound ablation of symptomatic uterine fibroids. In: MR-guided focused ultrasound 2010 2nd International Symposium. Washington, DC; 2010. p. 119.Google Scholar
  54. 54.
    Kim Y-s, Lim HK, Kim J-H, Rhim H, Keserci B. Dynamic contrast-enhanced magnetic resonance imaging predicts immediate therapeutic response of MR-guided high-intensity focused ultrasound ablation of symptomatic uterine fibroids. In: MR-guided focused ultrasound 2010. Washington, DC; 2010. p. 118.Google Scholar
  55. 55.
    O’Sullivan AK, Thompson D, Chu P, Lee DW, Stewart EA, Weinstein MC. Cost-effectiveness of magnetic resonance guided focused ultrasound for the treatment of uterine fibroids. Int J Technol Assess Health Care. 2009;25:14–25.CrossRefPubMedPubMedCentralGoogle Scholar
  56. 56.
    Zowall H, Cairns JA, Brewer C, Lamping DL, Gedroyc WM, Regan L. Cost-effectiveness of magnetic resonance-guided focused ultrasound surgery for treatment of uterine fibroids. BJOG. 2008;115:653–62.CrossRefPubMedPubMedCentralGoogle Scholar
  57. 57.
    Stewart E, editor. Uterine fibroids: the complete guide. 1st ed. Baltimore: Johns Hopkins University Press; 2007.Google Scholar
  58. 58.
    Hesley GK, Felmlee JP, Gebhart JB, et al. Noninvasive treatment of uterine fibroids: early Mayo clinic experience with magnetic resonance imaging-guided focused ultrasound. Mayo Clin Proc. 2006;81:936–42.CrossRefPubMedGoogle Scholar
  59. 59.
    Rabinovici J, Inbar Y, Revel A, et al. Clinical improvement and shrinkage of uterine fibroids after thermal ablation by magnetic resonance-guided focused ultrasound surgery. Ultrasound Obstet Gynecol. 2007;30:771–7.CrossRefPubMedGoogle Scholar
  60. 60.
    Bouwsma E, Stewart EA, Gorny K, Hesley G. In: MR-guided focused ultrasound 2010 2nd International Symposium. Washington, DC; 2010. p. 119.Google Scholar
  61. 61.
    Rabinovici J, David M, Fukunishi H, Morita Y, Gostout BS, Stewart EA. Pregnancy outcome after magnetic resonance-guided focused ultrasound surgery (MRgFUS) for conservative treatment of uterine fibroids. Fertil Steril. 2010;93:199–209.CrossRefPubMedGoogle Scholar
  62. 62.
    Gavrilova-Jordan LP, Rose CH, Traynor KD, Brost BC, Gostout BS. Successful term pregnancy following MR-guided focused ultrasound treatment of uterine leiomyoma. J Perinatol. 2007;27:59–61.CrossRefPubMedGoogle Scholar
  63. 63.
    Rabinovici J, Inbar Y, Eylon SC, Schiff E, Hananel A, Freundlich D. Pregnancy and live birth after focused ultrasound surgery for symptomatic focal adenomyosis: a case report. Hum Reprod. 2006;21:1255–9.CrossRefPubMedGoogle Scholar
  64. 64.
    Morita Y, Ito N, Ohashi H. Pregnancy following MR-guided focused ultrasound surgery for a uterine fibroid. Int J Gynaecol Obstet. 2007;99:56–7.CrossRefPubMedGoogle Scholar
  65. 65.
    Hanstede MM, Tempany CM, Stewart EA. Focused ultrasound surgery of intramural leiomyomas may facilitate fertility: a case report. Fertil Steril. 2007;88:497 e5–7.CrossRefGoogle Scholar
  66. 66.
    Smart OC, Hindley JT, Regan L, Gedroyc WM. Magnetic resonance guided focused ultrasound surgery of uterine fibroids–the tissue effects of GnRH agonist pre-treatment. Eur J Radiol. 2006;59:163–7.CrossRefPubMedGoogle Scholar
  67. 67.
    Taran FA, Hesley GK, Gorny KR, Stewart EA. What factors currently limit magnetic resonance-guided focused ultrasound of leiomyomas? A survey conducted at the first international symposium devoted to clinical magnetic resonance-guided focused ultrasound. Fertil Steril. 2010;94:331–4.CrossRefPubMedGoogle Scholar
  68. 68.
    Farquhar C, Brosens I. Medical and surgical management of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2006;20:603–16.CrossRefPubMedGoogle Scholar
  69. 69.
    Banu NS, Manyonda IT. Alternative medical and surgical options to hysterectomy. Best Pract Res Clin Obstet Gynaecol. 2005;19:431–49.CrossRefPubMedGoogle Scholar
  70. 70.
    Rabinovici J, Stewart EA. New interventional techniques for adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2006;20:617–36.CrossRefPubMedGoogle Scholar
  71. 71.
    Roman JD. Surgical treatment of endometriosis in private practice: cohort study with mean follow-up of 3 years. J Minim Invasive Gynecol. 2010;17:42–6.CrossRefPubMedGoogle Scholar
  72. 72.
    McCausland V, McCausland A. The response of adenomyosis to endometrial ablation/resection. Hum Reprod Update. 1998;4:350–9.CrossRefPubMedGoogle Scholar
  73. 73.
    Keckstein J. Hysteroscopy and adenomyosis. Contrib Gynecol Obstet. 2000;20:41–50.CrossRefPubMedGoogle Scholar
  74. 74.
    Levgur M. Therapeutic options for adenomyosis: a review. Arch Gynecol Obstet. 2007;276:1–15.CrossRefPubMedGoogle Scholar
  75. 75.
    Kim MD, Kim S, Kim NK, et al. Long-term results of uterine artery embolization for symptomatic adenomyosis. AJR Am J Roentgenol. 2007;188:176–81.CrossRefPubMedGoogle Scholar
  76. 76.
    Pelage JP, Le Dref O, Jacob D, et al. Uterine artery embolization: anatomical and technical considerations, indications, results, and complications. J Radiol. 2000;81:1863–72.PubMedGoogle Scholar
  77. 77.
    Bratby MJ, Walker WJ. Uterine artery embolisation for symptomatic adenomyosis–mid-term results. Eur J Radiol. 2009;70:128–32.CrossRefPubMedGoogle Scholar
  78. 78.
    Pelage JP, Jacob D, Fazel A, et al. Midterm results of uterine artery embolization for symptomatic adenomyosis: initial experience. Radiology. 2005;234:948–53.CrossRefPubMedGoogle Scholar
  79. 79.
    Wang W, Wang Y, Tang J. Safety and efficacy of high intensity focused ultrasound ablation therapy for adenomyosis. Acad Radiol. 2009;16:1416–23.CrossRefPubMedGoogle Scholar
  80. 80.
    Yoon SW, Kim KA, Cha SH, et al. Successful use of magnetic resonance-guided focused ultrasound surgery to relieve symptoms in a patient with symptomatic focal adenomyosis. Fertil Steril. 2018;2008(90):2018 e13–5.Google Scholar
  81. 81.
    Fukunishi H, Funaki K, Sawada K, Yamaguchi K, Maeda T, Kaji Y. Early results of magnetic resonance-guided focused ultrasound surgery of adenomyosis: analysis of 20 cases. J Minim Invasive Gynecol. 2008;15:571–9.CrossRefPubMedGoogle Scholar
  82. 82.
    Singer A. The uterine cervix from adolescence to the menopause. Br J Obstet Gynaecol. 1975;82:81–99.CrossRefPubMedGoogle Scholar
  83. 83.
    Mayeaux Jr EJ, Spigener SD, German JA. Cryotherapy of the uterine cervix. J Fam Pract. 1998;47:99–102.PubMedGoogle Scholar
  84. 84.
    Chen J, Zhou D, Liu Y, et al. A comparison between ultrasound therapy and laser therapy for symptomatic cervical ectopy. Ultrasound Med Biol. 2008;34:1770–4.CrossRefPubMedGoogle Scholar
  85. 85.
    Patterson GK, Winburn GB. Abdominal wall endometriomas: report of eight cases. Am Surg. 1999;65:36–9.PubMedGoogle Scholar
  86. 86.
    Dwivedi AJ, Agrawal SN, Silva YJ. Abdominal wall endometriomas. Dig Dis Sci. 2002;47:456–61.CrossRefPubMedGoogle Scholar
  87. 87.
    Hughes ML, Bartholomew D, Paluzzi M. Abdominal wall endometriosis after amniocentesis. A case report. J Reprod Med. 1997;42:597–9.PubMedGoogle Scholar
  88. 88.
    Gunes M, Kayikcioglu F, Ozturkoglu E, Haberal A. Incisional endometriosis after cesarean section, episiotomy and other gynecologic procedures. J Obstet Gynaecol Res. 2005;31:471–5.CrossRefPubMedGoogle Scholar
  89. 89.
    Blanco RG, Parithivel VS, Shah AK, Gumbs MA, Schein M, Gerst PH. Abdominal wall endometriomas. Am J Surg. 2003;185:596–8.CrossRefPubMedGoogle Scholar
  90. 90.
    Kocakusak A, Arpinar E, Arikan S, Demirbag N, Tarlaci A, Kabaca C. Abdominal wall endometriosis: a diagnostic dilemma for surgeons. Med Princ Pract. 2005;14:434–7.CrossRefPubMedGoogle Scholar
  91. 91.
    Wang Y, Wang W, Wang L, Wang J, Tang J. Ultrasound-guided high-intensity focused ultrasound treatment for abdominal wall endometriosis: preliminary results. Eur J Radiol. 2011;79(1):56–9CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of Radiological SciencesRonald Regan UCLA Medical CenterLos AngelesUSA

Personalised recommendations